anecortave acetate has been researched along with Macular Degeneration in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 31 (96.88) | 29.6817 |
| 2010's | 1 (3.13) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geltzer, A; Turalba, A; Vedula, SS | 2 |
| Augustin, AJ; Offermann, I | 1 |
| Aggermann, T; Binder, S; Haas, P | 1 |
| D'Amico, DJ; Goldberg, MF; Hudson, H; Jerdan, JA; Krueger, S; Luna, S; Robertson, SM; Russell, S; Singerman, L; Slakter, JS; Sullivan, EK; Yannuzzi, L; Zilliox, P | 1 |
| Joussen, AM; Kirchhof, B | 1 |
| Coscas, G; Haddad, W; Razavi, S; Roquet, W; Soubrane, G; Souied, E | 1 |
| D'Amico, DJ; Goldberg, MF; Hudson, H; Jerdan, JA; Krueger, DS; Luna, SP; Robertson, SM; Russell, S; Singerman, L; Slakter, JS; Yannuzzi, L; Zilliox, P | 1 |
| Augustin, AJ; Beasley, C; D'Amico, DJ; Mieler, WF; Schneebaum, C | 1 |
| Clarke, MS | 1 |
| Toris, C | 1 |
| Schachat, AP | 1 |
| Bochow, TW; D'Amico, DJ; Jerdan, J; Marks, B; Robertson, SM; Slakter, JS; Sullins, G; Sullivan, EK; Zilliox, P | 1 |
| Gillespie, BW; Musch, DC | 1 |
| Bakri, SJ; Kaiser, PK | 1 |
| Donaldson, MJ; Pulido, JS | 1 |
| Bandello, F; Chakravarthy, U; Chong, V; Creuzot-Garcher, C; Dimitrakos, SA; Korobelnik, JF; Larsen, M; Monés, J; Pauleikhoff, D; Pournaras, CJ; Soubrane, G; Staurenghi, G; Virgili, G; Wolf, S | 1 |
| Slakter, JS | 1 |
| Eandi, CM; Freund, KB; Klais, CM; Ober, MD; Sadeghi, SN; Slakter, JS; Sorenson, JA; Spaide, RF; Yannuzzi, LA | 1 |
| Jampol, LM; Weinberg, DV | 1 |
| Del Priore, LV; Shah, AR | 1 |
| Clark, AF | 1 |
| Beasley, CH; D'Amico, DJ; Mieler, WF; Regillo, CD; Schneebaum, C; Sullins, GT | 1 |
| Hudson, HL; Jerdan, JA; Russell, SR | 1 |
| Carvalho, C; Coleman, H; Slakter, JS | 1 |
| Bienias, W; Nowak, JZ | 1 |
| Barthelmes, D; Fleischhauer, JC; Hayek, S; Helbig, H; Kurz-Levin, MM; Menghini, M; Scherrer, M; Sutter, FK | 1 |
| Emerson, MV; Lauer, AK | 1 |
| Augustin, A | 1 |
15 review(s) available for anecortave acetate and Macular Degeneration
| Article | Year |
|---|---|
Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration.
Topics: Angiogenesis Inhibitors; Choroidal Neovascularization; Drug Implants; Humans; Macular Degeneration; Photochemotherapy; Pregnadienediols; Randomized Controlled Trials as Topic; Triamcinolone Acetonide | 2013 |
[Is there a drug therapy for age-related macular degeneration?--current status and new therapeutic approaches].
Topics: Alprostadil; Angiogenesis Inhibitors; Antioxidants; Choroidal Neovascularization; Clinical Trials as Topic; Combined Modality Therapy; Humans; Macular Degeneration; Photochemotherapy; Pregnadienediols; Triamcinolone; Vascular Endothelial Growth Factor A | 2008 |
[Alternative therapies for choroidal neovessels resulting from age-related macular degeneration].
Topics: Angiogenesis Inhibitors; Animals; Antioxidants; Choroidal Neovascularization; Disease Models, Animal; Fovea Centralis; Humans; Hyperthermia, Induced; Macular Degeneration; Multicenter Studies as Topic; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Porphyrins; Pregnadienediols; Pupil; Randomized Controlled Trials as Topic; Vascular Endothelial Growth Factor A; Verteporfin; Visual Acuity; Zinc | 2003 |
Anecortave acetate.
Topics: Animals; Drugs, Investigational; Humans; Macular Degeneration; Pregnadienediols | 2006 |
Treatment of nonexudative (dry) age-related macular degeneration.
Topics: Angiogenesis Inhibitors; Exudates and Transudates; Humans; Laser Therapy; Lutein; Macular Degeneration; Plasmapheresis; Pregnadienediols; Retinal Drusen; Xanthophylls; Zeaxanthins | 2006 |
Anecortave acetate for treating or preventing choroidal neovascularization.
Topics: Angiogenesis Inhibitors; Animals; Choroidal Neovascularization; Humans; Macular Degeneration; Pregnadienediols; Treatment Outcome | 2006 |
Progressive visual loss in subfoveal exudation in age-related macular degeneration: a meta-analysis using Lineweaver-Burke plots.
Topics: Angiogenesis Inhibitors; Aptamers, Nucleotide; Blindness; Choroidal Neovascularization; Disease Progression; Exudates and Transudates; Humans; Macula Lutea; Macular Degeneration; Photochemotherapy; Pregnadienediols; Randomized Controlled Trials as Topic; Retrospective Studies; Vascular Endothelial Growth Factor A; Visual Acuity | 2007 |
Preclinical efficacy of anecortave acetate.
Topics: Angiogenesis Inhibitors; Animals; Choroidal Neovascularization; Disease Models, Animal; Drug Evaluation, Preclinical; Macular Degeneration; Neoplasms; Pregnadienediols; Treatment Outcome | 2007 |
Clinical safety profile of posterior juxtascleral depot administration of anecortave acetate 15 mg suspension as primary therapy or adjunctive therapy with photodynamic therapy for treatment of wet age-related macular degeneration.
Topics: Angiogenesis Inhibitors; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Humans; Macular Degeneration; Photochemotherapy; Pregnadienediols; Sclera; Suspensions | 2007 |
Anecortave acetate for the treatment of exudative age-related macular degeneration--a review of clinical outcomes.
Topics: Angiogenesis Inhibitors; Choroidal Neovascularization; Clinical Trials as Topic; Exudates and Transudates; Humans; Macular Degeneration; Pregnadienediols; Treatment Outcome | 2007 |
The Digital Angiography Reading Center (DARC) role in the anecortave acetate clinical trials.
Topics: Angiogenesis Inhibitors; Clinical Trials as Topic; Fluorescein Angiography; Humans; Macular Degeneration; Photography; Pregnadienediols; Signal Processing, Computer-Assisted | 2007 |
[Age-related macular degeneration (AMD): etiopathogenesis and therapeutic strategies].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antioxidants; Aptamers, Nucleotide; Bevacizumab; Humans; Lipofuscin; Macular Degeneration; Neovascularization, Pathologic; Photochemotherapy; Pregnadienediols; Ranibizumab; Retinal Drusen; Triamcinolone Acetonide | 2007 |
Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Cholestanols; Choroidal Neovascularization; Diabetic Retinopathy; Drug Therapy, Combination; Humans; Indoles; Lactates; Laser Coagulation; Macular Degeneration; Macular Edema; Maleimides; Octreotide; Photochemotherapy; Photosensitizing Agents; Porphyrins; Pregnadienediols; Protein-Tyrosine Kinases; Vascular Endothelial Growth Factors; Verteporfin; Vitrectomy | 2007 |
Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration.
Topics: Angiogenesis Inhibitors; Choroidal Neovascularization; Drug Implants; Humans; Macular Degeneration; Pregnadienediols; Randomized Controlled Trials as Topic; Triamcinolone Acetonide | 2007 |
Anecortave acetate in the treatment of age-related macular degeneration.
Topics: Aged; Germany; Humans; Macular Degeneration; Middle Aged; Pregnadienediols | 2006 |
6 trial(s) available for anecortave acetate and Macular Degeneration
| Article | Year |
|---|---|
Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): interim (month 6) analysis of clinical safety and efficacy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Double-Blind Method; Exudates and Transudates; Female; Fluorescein Angiography; Fovea Centralis; Humans; Macular Degeneration; Male; Middle Aged; Pregnadienediols; Prospective Studies; Safety; Treatment Outcome; Visual Acuity | 2003 |
Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Coloring Agents; Double-Blind Method; Drug Evaluation; Female; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis; Humans; Indocyanine Green; Macular Degeneration; Male; Pregnadienediols; Prospective Studies; Safety; Treatment Outcome; Visual Acuity | 2003 |
Safety of posterior juxtascleral depot administration of the angiostatic cortisene anecortave acetate for treatment of subfoveal choroidal neovascularization in patients with age-related macular degeneration.
Topics: Angiogenesis Inhibitors; Choroidal Neovascularization; Delayed-Action Preparations; Drug Delivery Systems; Fluorescein Angiography; Fovea Centralis; Humans; Intraocular Pressure; Macular Degeneration; Pregnadienediols; Safety; Sclera; Visual Acuity | 2005 |
Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Connective Tissue; Double-Blind Method; Female; Fluorescein Angiography; Fovea Centralis; Humans; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Pregnadienediols; Prospective Studies; Treatment Outcome; Verteporfin; Visual Acuity | 2006 |
Anecortave acetate treatment for retinal angiomatous proliferation: a pilot study.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Angiomatosis; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Injections; Intraocular Pressure; Macular Degeneration; Male; Pilot Projects; Pregnadienediols; Prospective Studies; Retinal Neovascularization; Retinal Vessels; Tomography, Optical Coherence; Visual Acuity | 2006 |
First clinical experience with anecortave acetate (Retaane).
Topics: Aged; Angiogenesis Inhibitors; Choroidal Neovascularization; Female; Humans; Injections; Macular Degeneration; Male; Pilot Projects; Pregnadienediols; Treatment Outcome; Vision Disorders; Visual Acuity | 2007 |
11 other study(ies) available for anecortave acetate and Macular Degeneration
| Article | Year |
|---|---|
Anecortave acetate for fibrotic lesions with presence of residual peripheral activity in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Female; Fibrosis; Humans; Injections; Macular Degeneration; Male; Pregnadienediols; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2008 |
[Angiogenesis in ophthalmology. A theme with a future].
Topics: Adult; Angiogenesis Inhibitors; Antineoplastic Agents; Choroidal Neovascularization; Corneal Neovascularization; Diabetic Retinopathy; Endothelial Growth Factors; Eye Diseases; Humans; Infant, Newborn; Intercellular Signaling Peptides and Proteins; Lymphokines; Macular Degeneration; Metalloendopeptidases; Neovascularization, Pathologic; Organic Chemicals; Platelet-Derived Growth Factor; Pregnadienediols; Retinal Neovascularization; Retinopathy of Prematurity; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Anecortave acetate.
Topics: Angiogenesis Inhibitors; Biological Availability; Biological Transport; Choroidal Neovascularization; Dose-Response Relationship, Drug; Humans; Macular Degeneration; Pregnadienediols | 2004 |
Association for Ocular Pharmacology and Therapeutics--Seventh Meeting. 3-5 February 2005, Catania, Italy.
Topics: Chemistry, Pharmaceutical; Clinical Trials, Phase III as Topic; Eye Diseases; Humans; Macular Degeneration; Molecular Structure; Ophthalmic Solutions; Pregnadienediols; Receptors, Vascular Endothelial Growth Factor; Societies, Medical | 2005 |
New treatments for age-related macular degeneration.
Topics: Aptamers, Nucleotide; Dietary Supplements; Humans; Laser Coagulation; Macular Degeneration; Oligonucleotides; Ophthalmologic Surgical Procedures; Photochemotherapy; Pregnadienediols | 2005 |
The state of being noninferior.
Topics: Antihypertensive Agents; Choroidal Neovascularization; Clinical Trials as Topic; Drug Therapy, Combination; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Macular Degeneration; Photochemotherapy; Practice Guidelines as Topic; Pregnadienediols; Prostaglandins F, Synthetic; Research Design; Timolol | 2006 |
[Comments on current therapeutic possibilities for neovascular age-related macula degeneration].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Choroidal Neovascularization; Germany; Glucocorticoids; Humans; Laser Coagulation; Macular Degeneration; Photochemotherapy; Porphyrins; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pregnadienediols; Ranibizumab; Triamcinolone; Verteporfin | 2006 |
Macular degeneration. Advances in treatment.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antioxidants; Aptamers, Nucleotide; Glucocorticoids; Humans; Light Coagulation; Macular Degeneration; Photochemotherapy; Pregnadienediols; Ranibizumab; Triamcinolone | 2006 |
Evolving European guidance on the medical management of neovascular age related macular degeneration.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Choroidal Neovascularization; Evidence-Based Medicine; Humans; Macular Degeneration; Photochemotherapy; Pregnadienediols; Ranibizumab; Treatment Outcome; Triamcinolone Acetonide | 2006 |
Treatment of choroidal neovascularization in AMD.
Topics: Angiogenesis Inhibitors; Choroidal Neovascularization; Clinical Trials, Phase III as Topic; Humans; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Porphyrins; Pregnadienediols; Treatment Outcome; Verteporfin | 2006 |
[Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists in Germany on the current therapeutic possibilities for neovascular age-related macular degeneration].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Choroidal Neovascularization; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Macular Degeneration; Ophthalmology; Photochemotherapy; Porphyrins; Pregnadienediols; Ranibizumab; Societies, Medical; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Verteporfin | 2007 |